{"donor_id":"TARGET-10-PAIXDK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"6","donor_age_at_last_followup":"10","donor_relapse_interval":"1169","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2037","donor_interval_of_last_followup":"2037","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXFI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXFN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":"16","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1068","donor_interval_of_last_followup":"1068","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXGP","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXPH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":"169","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXPN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAIXSD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":null,"donor_relapse_interval":"1083","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKFLH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"19","donor_age_at_enrollment":"19","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKFRR","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":"522","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKFYA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":"18","donor_relapse_interval":"1376","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2023","donor_interval_of_last_followup":"2023","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKGEE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKGHN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKGUA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKGZB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":"376","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKHNA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"10","donor_age_at_last_followup":"12","donor_relapse_interval":"510","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"715","donor_interval_of_last_followup":"715","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKHSB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"11","donor_age_at_enrollment":"10","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKHSV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKHUK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":"3593","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKHZT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":"14","donor_relapse_interval":"355","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"605","donor_interval_of_last_followup":"605","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKIFK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":"455","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKJAA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"9","donor_age_at_last_followup":"12","donor_relapse_interval":"1205","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2403","donor_interval_of_last_followup":"2403","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKJDY","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"11","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKJGT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKKCA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKKMW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKKXB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKLGW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKLRH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":"4","donor_relapse_interval":"700","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"956","donor_interval_of_last_followup":"956","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKLSW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKMEU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKMJF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":"19","donor_relapse_interval":"558","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1178","donor_interval_of_last_followup":"1178","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKMVD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKMZM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":"21","donor_relapse_interval":"1229","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1914","donor_interval_of_last_followup":"1914","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKNMN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":"21","donor_relapse_interval":"1596","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2694","donor_interval_of_last_followup":"2694","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKNPC","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKNWJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":"15","donor_relapse_interval":"362","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"485","donor_interval_of_last_followup":"485","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKNZV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKPFV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":"19","donor_relapse_interval":"606","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1306","donor_interval_of_last_followup":"1306","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKPVX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKRGU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"4","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKRSL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":"15","donor_relapse_interval":"670","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"705","donor_interval_of_last_followup":"705","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKRXU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"3","donor_age_at_last_followup":"5","donor_relapse_interval":"905","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2361","donor_interval_of_last_followup":"2361","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKSEH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKSRG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"6","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKSSH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKSWW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":"16","donor_relapse_interval":"532","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1592","donor_interval_of_last_followup":"1592","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKTAL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"12","donor_age_at_last_followup":"15","donor_relapse_interval":"1043","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1061","donor_interval_of_last_followup":"1061","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKTWI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKUCV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKUGY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKUKG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKUPP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKUPX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKVKF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":"21","donor_relapse_interval":"1249","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1296","donor_interval_of_last_followup":"1296","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKVKK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":"512","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKVTS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKWEA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKWSH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKWWU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":"16","donor_relapse_interval":"344","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"496","donor_interval_of_last_followup":"496","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXAB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1916","donor_interval_of_last_followup":"1916","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXDI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":"550","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXDY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"12","donor_age_at_last_followup":"12","donor_relapse_interval":"246","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1580","donor_interval_of_last_followup":"1580","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXIM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXZB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":"22","donor_relapse_interval":"1777","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2521","donor_interval_of_last_followup":"2521","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKXZT","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYBE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYEI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"7","donor_age_at_last_followup":"11","donor_relapse_interval":"1399","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1814","donor_interval_of_last_followup":"1814","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYEN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"7","donor_age_at_enrollment":"6","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYEP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":"464","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYKZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":"1134","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKYNG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"11","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKZHH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAKZXD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":"1382","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALALW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALASH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"6","donor_age_at_enrollment":"6","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALAVI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":"1779","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALAVV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALAWA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":"3","donor_relapse_interval":"279","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"508","donor_interval_of_last_followup":"508","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALAZR","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALAZT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALBBU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALBFZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"6","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALBHP","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALBLM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALBLX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALCAZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALCBE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":"445","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALCDL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALCJJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":"1604","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALCTA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALDBN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALDGI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALDHH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":"18","donor_relapse_interval":"505","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1996","donor_interval_of_last_followup":"1996","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALDZA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALECK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALESZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALETF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"7","donor_age_at_last_followup":"9","donor_relapse_interval":"650","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"768","donor_interval_of_last_followup":"768","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFBA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"10","donor_age_at_last_followup":"15","donor_relapse_interval":"1604","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2299","donor_interval_of_last_followup":"2299","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFBU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFGE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":"1017","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFHL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFKB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":"1622","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFKF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":"18","donor_relapse_interval":"334","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"379","donor_interval_of_last_followup":"379","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFNT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":"16","donor_relapse_interval":"1400","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2586","donor_interval_of_last_followup":"2586","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFWK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALFZF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":"1","donor_relapse_interval":"274","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"796","donor_interval_of_last_followup":"796","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALGAJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":"3","donor_relapse_interval":"609","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"792","donor_interval_of_last_followup":"792","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALGWT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALGXA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALGZR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALHIW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":"1137","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALHUG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALIBN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":"15","donor_relapse_interval":"569","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1041","donor_interval_of_last_followup":"1041","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALIEN","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"19","donor_age_at_enrollment":"19","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALIYC","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":"18","donor_relapse_interval":"51","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"203","donor_interval_of_last_followup":"203","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALIYD","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"11","donor_age_at_enrollment":"10","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALJAM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":"1864","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALJCF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALJDL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALJKB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"10","donor_age_at_enrollment":"9","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKDL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKDM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"20","donor_age_at_enrollment":"20","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKMF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKMM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":"13","donor_relapse_interval":"515","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1037","donor_interval_of_last_followup":"1037","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKTY","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"6","donor_age_at_last_followup":"9","donor_relapse_interval":"1310","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1507","donor_interval_of_last_followup":"1507","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKWG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKWV","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKXE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALKYT","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":"466","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLAD","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLAX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLGE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLGU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLLW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLSD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":"687","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLWU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":"147","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALLYD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALMBG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALMBV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"4","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALMCJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":"16","donor_relapse_interval":"1234","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1771","donor_interval_of_last_followup":"1771","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALMKZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":"24","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2903","donor_interval_of_last_followup":"2903","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALMTB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALNGC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALNGV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALNTB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"8","donor_age_at_last_followup":"11","donor_relapse_interval":"1023","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1415","donor_interval_of_last_followup":"1415","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALNTL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":"2","donor_relapse_interval":"183","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"246","donor_interval_of_last_followup":"246","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALNWA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALPEM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":"948","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALPJH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALPKP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALRFV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":"887","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALRGJ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALRUW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALRXE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALSJC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALSUM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALSXP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALTAG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALTIC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"6","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALTJS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"21","donor_age_at_enrollment":"20","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALTVZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALTWS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUAG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUAH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":"3","donor_relapse_interval":"400","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"476","donor_interval_of_last_followup":"476","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALULV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":"16","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"313","donor_interval_of_last_followup":"313","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALULW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":"1063","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUNK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"12","donor_age_at_last_followup":null,"donor_relapse_interval":"539","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUNS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"4","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALURE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":"16","donor_relapse_interval":"461","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"734","donor_interval_of_last_followup":"734","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUTW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALUVW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVBB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":"16","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"102","donor_interval_of_last_followup":"102","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVDI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":"7","donor_relapse_interval":"1245","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2012","donor_interval_of_last_followup":"2012","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVHL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVJA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"5","donor_age_at_enrollment":"5","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVKJ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"19","donor_age_at_enrollment":"18","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALVUR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":"17","donor_relapse_interval":"166","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"215","donor_interval_of_last_followup":"215","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALWAF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALWNJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":"20","donor_relapse_interval":"843","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1121","donor_interval_of_last_followup":"1121","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALWRE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALWVU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":"20","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2919","donor_interval_of_last_followup":"2919","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALXAM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"9","donor_age_at_enrollment":"9","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALXXU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"12","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALYDP","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALYMX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"1","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALYSM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":"18","donor_relapse_interval":"795","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"827","donor_interval_of_last_followup":"827","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALYXL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALYXW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALZJI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"12","donor_age_at_last_followup":"12","donor_relapse_interval":"171","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"243","donor_interval_of_last_followup":"243","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALZRM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
